Adam Raff, MD, PhD

Dr. Adam Raff is the Senior Vice President of Clinical Development at Orbital Therapeutics, where he leads clinical strategy and execution for a diverse therapeutic pipeline. With over a decade of experience, he brings deep scientific and clinical acumen to the development of novel therapies. Previously, Dr. Raff held senior leadership roles in clinical and translational development at companies including Montai Therapeutics, EQRx, and LEO Pharma.

Dr. Raff began his career as a physician-scientist at Massachusetts General Hospital and continues to practice dermatology at Beth Israel Lahey Health and hold a faculty appointment at Harvard Medical School. He received his MD and PhD in Immunology from the University of Southern California, completed his dermatology residency at Harvard, and a research fellowship at MGH. He also serves on the Research Leadership Council of Advancing Innovation in Dermatology.